Authors
Kshitija Kale, Chakrapani Vemulawada, Kai J Rogers, Michael P Crawford, Jace Heath, Nitin J Karandikar
Published in
ImmunoHorizons. Volume 10. Issue 11. Nov 05, 2026.
Abstract
T helper 17 (Th17) CD4+ T cells are key mediators of autoimmune pathology. Interleukin (IL)-1β is a potent proinflammatory cytokine known to promote Th17 differentiation and pathogenicity, in combination with other cytokines. Whereas recent studies have shown that T cells are capable of expressing IL-1β themselves, the role of this T cell-endogenous IL-1β is poorly understood. Using CRISPR/Cas9-mediated deletion of IL1B in naïve human CD4+ T cells along with cytokine neutralization and IL-1 receptor blockade, we found that T cell-intrinsic IL-1β is not essential for Th17 differentiation or effector resistance. Remarkably, single-cell RNA sequencing revealed that IL1B deletion profoundly rewires the transcriptional and metabolic landscape within the T cells, suppressing glycolytic and hypoxia-responsive pathways. These findings uncouple T cell-intrinsic IL-1β from Th17 effector resistance while uncovering an important contribution toward sustaining metabolic roles. This refines our understanding of IL-1β biology and informs therapeutic strategies in immune-mediated disease settings.
PMID:
43043978
Bibliographic data and abstract were imported from PubMed on 18 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 1
- Comments 0